Notices. Notice of availability; correction
212 words·~1 min read·
/register/2016/04/12/2016-08330·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 4164-01-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2016-D-0768] Donor Screening Recommendations To Reduce the Risk of Transmission of Zika Virus by Human Cells, Tissues, and Cellular and Tissue-Based Products; Guidance for Industry; Availability; Correction AGENCY: Food and Drug Administration, HHS. ACTION: Notice of availability; correction. SUMMARY: The Food and Drug Administration
(FDA)is correcting a notice that appeared in the **Federal Register** of Monday, March 7, 2016 (81 FR 11808). The document announced a guidance for industry entitled “Donor Screening Recommendations to Reduce the Risk of Transmission of Zika Virus by Human Cells, Tissues, and Cellular and Tissue-Based Products.” The document was published with an incorrect docket number in the ADDRESSES section. This document corrects that error. FOR FURTHER INFORMATION CONTACT: Lisa Granger, Office of Policy, Planning, Legislation, and Analysis, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, Rm. 3330, Silver Spring, MD 20993-0002, 301-796-9115. SUPPLEMENTARY INFORMATION: In FR Doc. 2016-04893, appearing on page 11808 in the **Federal Register** of Monday, March 7, 2016, the following correction is made: 1. On page 11808, in the third column, the docket number is corrected to read “FDA-2016-D-0768”. Dated: April 6, 2016. Leslie Kux, Associate Commissioner for Policy. [FR Doc. 2016-08330 Filed 4-11-16; 8:45 am]